Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies.
Tian H, Zhang T, Qin S, Huang Z, Zhou L, Shi J, Nice EC, Xie N, Huang C, Shen Z. · 2022
Read Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies. by Tian H, Zhang T, Qin S, Huang Z, Zhou L, Shi J, Nice EC, Xie N, Huang C, Shen Z. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9469622.txt.
Description
Tian and co-authors review targeted strategies that raise the power of nanoparticles in cancer treatment. Poor targeting is a core flaw of cancer therapy. Drugs hit healthy tissue and cause grave side effects. Nanoscale carriers can steer agents toward tumors instead.
One route uses ligands that lock onto tumor cell receptors. Folate and transferrin receptors are classic targets. Tumor vessels and antigens offer further handles. A second route uses stimuli-responsive platforms. These carriers stay quiet in normal tissue. At a tumor site, a trigger makes them release their cargo. Triggers include acidity, enzymes, and redox shifts. Hypoxia can serve as a trigger too. The authors sort the study stock by strategy. They close with what the field must fix for clinic use.
Catalog record
| CREATOR | Tian H, Zhang T, Qin S, Huang Z, Zhou L, Shi J, Nice EC, Xie N, Huang C, Shen Z. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 233 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |